Abintus Bio
PrivateLast Round
Series B
Aug 15, 2022
Total Funding Raised
$15.65M
Company Overview
Abintus Bio is a biotechnology company that develops in vivo genetic medicines designed to reprogram a patient's immune cells directly within the body.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abintus Bio Comparables
Compare Abintus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alaya.bio | 87% | |
| Eli Lilly and Company | 83% | |
| Umoja Biopharma | 78% |
Abintus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 15, 2022 | ||||
| Seed | Apr 22, 2021 |
Key People
Founding team and executive leadership
Abintus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skyviews Life Science | Series B |
| Tech Coast Angels | Series B |
| Leukemia & Lymphoma Society | Series B |
| SeedFolio | Series B |
| BioBrit | Series B |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Seed |
| Takeda Ventures | Seed, Series B |
Abintus Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Abintus Bio's valuation, stock price, and market status.
Is Abintus Bio a public or private company?
Abintus Bio is a private company.
What is the current stock price of Abintus Bio?
Abintus Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Abintus Bio worth (valuation)?
Valuation information for Abintus Bio is not publicly available.
Can I buy Abintus Bio stock?
Abintus Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Abintus Bio's last funding round?
Abintus Bio's most recent funding round was Series B on August 15, 2022.
Who are the main investors in Abintus Bio?
Key investors in Abintus Bio include Skyviews Life Science, Tech Coast Angels, Leukemia & Lymphoma Society, SeedFolio, BioBrit.
Will Abintus Bio IPO soon?
No public IPO plans have been announced for Abintus Bio.
How can I track Abintus Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abintus Bio's secondary market activity and sign up for updates.